Resources

Mosaic Therapeutics, Ltd, a targeted oncology therapeutics company dedicated to resolving cancer’s complexity with new combination therapies for patients, today announces the in-licensing of two clinical-stage oncology programs from Astex Pharmaceuticals, a wholly owned subsidiary of Otsuka Pharmaceutical Co. Ltd.

Amid ongoing geopolitical uncertainty, the UK life sciences ecosystem is keeping calm and carrying on.

A Phase-1b Dose Escalation Study to Assess the Effect of NG11-2 on Radiation Induced Oral Mucositis (RIOM) in Patients with Head & Neck Cancer.

On 6 March 2025, just ahead of International Women’s Day, the BioIndustry Association (BIA) hosted the Women in Biotech Cambridge event—a vibrant gathering of trailblazing women shaping the life sciences landscape.

Stablepharma Ltd receives MHRA approval for Phase 1 trial of fridge-free tetanus and diphtheria (Td) vaccine.

Stablepharma Ltd has secured a €2.5 million EIC Accelerator grant, recognizing its pioneering fridge-free pharmaceutical technology.

 This week’s blog explores the dynamic intersection of life sciences, policy, and innovation. From groundbreaking collaborations in the UK to navigating the shifting IP landscape in North America, I reflect on how our sector continues to lead and adapt in a rapidly changing world.

Conduit Pharmaceuticals Partners with Agility Life Sciences to Create Enhanced Formulations for its Autoimmune Pipeline.

This latest research builds upon the growing body of evidence demonstrating the unique impact of Brainomix’s AI-powered software to expand access to life-changing stroke treatments across networks.

Precision BioSearch was delighted to partner with Optieum Biotechnologies Inc. (“Optieum”), a biotechnology company focused on discovering and developing innovative CAR-T cell therapies, to secure the appointment of Dr. Dan MacLeod as Chief Scientific Officer.

This week our new BIA UK biotech financing report shows £3.5 billion invested in 2024, I detail the launch of the STVC Fellowship, look at the impact of the proposed US withdrawal from WHO, and news from Davos on groundbreaking AI-driven drug trials by Isomorphic Labs.

The UK’s Cell and Gene Therapy Catapult has published new insights into the advancement of the UK’s cell and gene therapy industry in its 2024 ATMP Clinical Trials Database.

Scancell Holdings plc (AIM: SCLP), a clinical-stage biopharmaceutical company developing novel immunotherapies for cancer, has achieved significant clinical and commercial milestones in its ModiFY study.

J.P. Morgan Healthcare Conference 2025: Genomics announces Dr. Jose-Carlos Gutiérrez-Ramos as new board member to accelerate global expansion and life sciences R&D growth.

The global life science investment and media community are heading to the JPM Healthcare Conference next week and we’ll be keeping an eye on announcements and grants that impact our industry.

David Apelian MD PhD MBA, an experienced CEO with significant development and regulatory experience in virology and immune-oncology joins Theolytics.

New legislation was laid in Parliament last Thursday to modernise the regulation of clinical trials in the UK.

Patients, the NHS and the Life Sciences sector set to benefit from new clinical trials framework being laid in parliament today.

Momentum Pharma breaks ground by becoming the first organization to receive new certification assessing highest industry standards.